Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case–Control Study in Sweden
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case–Control Study in Sweden
Authors
Keywords
-
Journal
ENVIRONMENTAL HEALTH PERSPECTIVES
Volume 130, Issue 3, Pages -
Publisher
Environmental Health Perspectives
Online
2022-03-14
DOI
10.1289/ehp9791
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Triglycerides and risk of atherosclerotic cardiovascular disease: An update
- (2021) Michel Farnier et al. Archives of Cardiovascular Diseases
- Per- and polyfluoroalkyl substances and calcifications of the coronary and aortic arteries in adults with prediabetes: Results from the diabetes prevention program outcomes study
- (2021) Citlalli Osorio-Yáñez et al. ENVIRONMENT INTERNATIONAL
- Temporal trends, 2000–2017, of perfluoroalkyl acid (PFAA) concentrations in serum of Swedish adolescents
- (2021) Erika Norén et al. ENVIRONMENT INTERNATIONAL
- Impairment of bile acid metabolism by perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in human HepaRG hepatoma cells
- (2020) Anne-Cathrin Behr et al. ARCHIVES OF TOXICOLOGY
- Albumin is the major carrier protein for PFOS, PFOA, PFHxS, PFNA and PFDA in human plasma
- (2020) Martin Forsthuber et al. ENVIRONMENT INTERNATIONAL
- Endocrine-disrupting chemicals: implications for human health
- (2020) Linda G Kahn et al. Lancet Diabetes & Endocrinology
- Mouse models of atherosclerosis and their suitability for the study of myocardial infarction
- (2020) Pelin Golforoush et al. BASIC RESEARCH IN CARDIOLOGY
- Plasma perfluoroalkyls are associated with decreased levels of proteomic inflammatory markers in a cross-sectional study of an elderly population
- (2020) S. Salihovic et al. ENVIRONMENT INTERNATIONAL
- Review: Evolution of evidence on PFOA and health following the assessments of the C8 Science Panel
- (2020) Kyle Steenland et al. ENVIRONMENT INTERNATIONAL
- The Confounder-Mediator Dilemma: Should We Control for Obesity to Estimate the Effect of Perfluoroalkyl Substances on Health Outcomes?
- (2020) Kosuke Inoue et al. Toxics
- Using 2003–2014 U.S. NHANES data to determine the associations between per- and polyfluoroalkyl substances and cholesterol: Trend and implications
- (2019) Zhaomin Dong et al. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
- Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study
- (2019) Annika Rosengren et al. Lancet Global Health
- Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
- (2019) Salim Yusuf et al. LANCET
- Perfluoroalkyl substances and likelihood of stroke in persons with and without diabetes
- (2019) Robert Hutcheson et al. Diabetes & Vascular Disease Research
- Atherosclerosis and inflammation: overview and updates
- (2018) Glaucylara Reis Geovanini et al. CLINICAL SCIENCE
- Serum polyfluoroalkyl chemicals are associated with risk of cardiovascular diseases in national US population
- (2018) Mengmeng Huang et al. ENVIRONMENT INTERNATIONAL
- Changes in plasma levels of perfluoroalkyl substances (PFASs) are related to increase in carotid intima-media thickness over 10 years – a longitudinal study
- (2018) P. Monica Lind et al. Environmental Health
- Exposure to per-fluoroalkyl and polyfluoroalkyl substances leads to immunotoxicity: epidemiological and toxicological evidence
- (2018) Jamie C. DeWitt et al. Journal of Exposure Science and Environmental Epidemiology
- A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects
- (2018) Elsie M. Sunderland et al. Journal of Exposure Science and Environmental Epidemiology
- Roles of gender and obesity in defining correlations between perfluoroalkyl substances and lipid/lipoproteins
- (2018) Ram B. Jain et al. SCIENCE OF THE TOTAL ENVIRONMENT
- Perfluoroalkyl substances and risk of type II diabetes: A prospective nested case-control study
- (2018) Carolina Donat-Vargas et al. ENVIRONMENT INTERNATIONAL
- Circulating levels of perfluoroalkyl substances (PFASs) and carotid artery atherosclerosis
- (2017) P. Monica Lind et al. ENVIRONMENTAL RESEARCH
- Drinking water contamination from perfluoroalkyl substances (PFAS): an ecological mortality study in the Veneto Region, Italy
- (2017) Marina Mastrantonio et al. EUROPEAN JOURNAL OF PUBLIC HEALTH
- Per- and Polyfluoroalkyl Substances (PFASs) in Food and Human Dietary Intake: A Review of the Recent Scientific Literature
- (2017) José L. Domingo et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years
- (2017) Philippe Grandjean et al. Journal of Immunotoxicology
- Perfluorooctane Sulfonate-Induced Hepatic Steatosis in Male Sprague Dawley Rats Is Not Attenuated by Dietary Choline Supplementation
- (2017) Bradford D Bagley et al. TOXICOLOGICAL SCIENCES
- Activation of nuclear receptor CAR by an environmental pollutant perfluorooctanoic acid
- (2016) Taiki Abe et al. ARCHIVES OF TOXICOLOGY
- Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis
- (2016) Kiran Musunuru et al. CIRCULATION RESEARCH
- The association of carotid intima-media thickness with serum Level of perfluorinated chemicals and endothelium-platelet microparticles in adolescents and young adults
- (2016) Chien-Yu Lin et al. ENVIRONMENT INTERNATIONAL
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Mohammad H Forouzanfar et al. LANCET
- A Mediterranean diet and risk of myocardial infarction, heart failure and stroke: A population-based cohort study
- (2015) Thanasis G. Tektonidis et al. ATHEROSCLEROSIS
- Levels of perfluoroalkyl substances and risk of coronary heart disease: Findings from a population-based longitudinal study
- (2015) Kristina Mattsson et al. ENVIRONMENTAL RESEARCH
- Na+/Taurocholate Cotransporting Polypeptide and Apical Sodium-Dependent Bile Acid Transporter Are Involved in the Disposition of Perfluoroalkyl Sulfonates in Humans and Rats
- (2015) Wen Zhao et al. TOXICOLOGICAL SCIENCES
- Fish Consumption and Acute Coronary Syndrome: A Meta-Analysis
- (2014) Sylvie S.L. Leung Yinko et al. AMERICAN JOURNAL OF MEDICINE
- Modeled PFOA Exposure and Coronary Artery Disease, Hypertension, and High Cholesterol in Community and Worker Cohorts
- (2014) Andrea Winquist et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Associations between PFOA, PFOS and changes in the expression of genes involved in cholesterol metabolism in humans
- (2013) Tony Fletcher et al. ENVIRONMENT INTERNATIONAL
- Reductions in Serum Lipids with a 4-year Decline in Serum Perfluorooctanoic Acid and Perfluorooctanesulfonic Acid
- (2013) Nicola Fitz-Simon et al. EPIDEMIOLOGY
- In vitro toxicological characterization of perfluorinated carboxylic acids with different carbon chain lengths
- (2013) Thorsten Buhrke et al. TOXICOLOGY LETTERS
- The effect of androgens on lipids
- (2013) Anne K. Monroe et al. Current Opinion in Endocrinology Diabetes and Obesity
- Perfluorooctanoic Acid and Cardiovascular Disease in US Adults
- (2012) Anoop Shankar et al. ARCHIVES OF INTERNAL MEDICINE
- Dietary exposure to perfluoroalkyl acids for the Swedish population in 1999, 2005 and 2010
- (2012) Robin Vestergren et al. ENVIRONMENT INTERNATIONAL
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- External review and validation of the Swedish national inpatient register
- (2011) Jonas F Ludvigsson et al. BMC PUBLIC HEALTH
- Perfluoroalkyl Sulfonates Cause Alkyl Chain Length–Dependent Hepatic Steatosis and Hypolipidemia Mainly by Impairing Lipoprotein Production in APOE*3-Leiden CETP Mice
- (2011) Silvia Bijland et al. TOXICOLOGICAL SCIENCES
- Environmental Risk Factors for Heart Disease
- (2011) T.E. O'Toole et al. REVIEWS ON ENVIRONMENTAL HEALTH
- Perfluorooctanoic Acid, Perfluorooctanesulfonate, and Serum Lipids in Children and Adolescents
- (2010) Stephanie J. Frisbee et al. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
- Estrogen-Like Activity of Perfluoroalkyl Acids In Vivo and Interaction with Human and Rainbow Trout Estrogen Receptors In Vitro
- (2010) Abby D. Benninghoff et al. TOXICOLOGICAL SCIENCES
- Association of Perfluorooctanoic Acid and Perfluorooctane Sulfonate With Serum Lipids Among Adults Living Near a Chemical Plant
- (2009) K. Steenland et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Structure-Activity Relationships and Human Relevance for Perfluoroalkyl Acid–Induced Transcriptional Activation of Peroxisome Proliferation in Liver Cell Cultures
- (2009) James A. Bjork et al. TOXICOLOGICAL SCIENCES
- Immunotoxicity of Perfluorooctanoic Acid and Perfluorooctane Sulfonate and the Role of Peroxisome Proliferator-Activated Receptor Alpha
- (2008) Jamie C. DeWitt et al. CRITICAL REVIEWS IN TOXICOLOGY
- Activation of Mouse and Human Peroxisome Proliferator−Activated Receptor Alpha by Perfluoroalkyl Acids of Different Functional Groups and Chain Lengths
- (2008) Cynthia J. Wolf et al. TOXICOLOGICAL SCIENCES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now